Preparation and in vitro characterization of paclitaxel-loaded injectable microspheres

Main Article Content

Jagadeesh G Hiremath
V Kusum Devi


The main objective of this study was to develop paclitaxel loaded poly (caprolactone) injectable microspheres prepared by solvent evaporation method. Mircoparticles were characterized in terms of particle size and size distribution, surface morphology, drug physical state, and crystalline nature by using master size analyzer, scanning electron microscope,differential scanning calorimetry, and X-ray diffraction. Paclitaxel loading over different concentrations was analyzed by high-performance liquid chromatography. In vitro drug release studies were performed in phosphate buffer saline. Best formulation was selected for in vitro cytotoxic studies by using MCF-7 breast cancer cell lines.


Download data is not yet available.

Article Details

How to Cite
Hiremath, J. G., & Devi, V. K. (2014). Preparation and in vitro characterization of paclitaxel-loaded injectable microspheres. Asian Journal of Pharmaceutics (AJP), 4(3).


Harpet E, Dang W, Lapidus RG, Garver RI. Enhanced efficacy of a novel

controlled release paclitaxel formulation (paclimer delivery system)

for local-regional therapy of lung cancer tumor nodules in mice. Clin

Cancer Res 1999;5:4242-8.

Johnston SR. Ovarian cancer: Review of the national institute for

clinical excellence (NICE) guidance recommendations. Cancer Invest


Watatani M, Ueda K, Daito K, Azumi T, Hirai T, Yamato M, et al. Clinical

experience of weekly paclitaxel based treatment as preoperative

chemotherapy for patients with primary breast cancer. Breast Cancer


Tarr BD, Yalkowsky SH. A new parenteral vehicle for the administration

of some poorly soluble anti-cancer drugs. J Parenter Sci Technol


Swindell CS, Krauss NE. Biologically active taxol analogues with

deleted A-ring side chain substituent and variable. J Med Chem 1991;


Straubinger RM. Taxol®: Science and Applications. 2nd ed. New York:

CRC Publishers; 1995. p. 237-54.

Wang YM, Sato H, Horikoshi I. In vitro and in vivo evaluation of taxol

release from poly (lactic-co-glycolic acid) microspheres containing

isopropyl myristate and degradation of the microspheres. J Control

Release 1997;49:157-66.

Paradis R, Page M. New active paclitaxel amino acids derivatives with

improved water solubility. Anticancer Res 1998;18:2711-6.

Zili Z, Sfar S, Fessi H. Preparation and characterization of poly

caprolactone nanoparticles containing griseofulvin. Int J Pharm


Hiremath JG, Kusum Devi V, Kshama Devi, Domb AJ. Biodegradable

Poly (sebacic acid-co-ricinoleic-ester anhydride) tamoxifen citrate

implants: Preparation and in vitro characterization. J J Appl Polymer

Sci 2007;107:2745-54.

Jeong JC, Lee J, Cho K. Effects of crystalline microstructure on drug

release behavior of polycaprolactone microspheres. J Control Release


Elkharraz K, Faisant N, Guse C, Siepmann F, Yegin BA, Oger JM. Paclitaxel

loaded microparticles and implants for the treatment of brain cancer:

Preparation and physical characterization. Int J Pharm 2006;137:127-36.

Mu L, Feng SS. Fabrication, characterization and in vitro release of

paclitaxel (Taxol®) loaded poly (lactic-co-glycolic acid) microspheres

prepared by spray drying technique with lipid/cholesterol emulsifiers.

J Control Release 2001;76:239-54.

Dubernet C. Thermo analysis of microspheres. Theor Chim Acta


Liggins RT, D’Amours S, Demetrick JS, Machan LS, Burt HM. Paclitaxel

loaded poly(l-lactic acid) microspheres for the prevention of

intraperitoneal carcinomatosis after a surgical repair and tumor cell

spill. Biomaterials 2000;19:1959-69.

Miglietta A, Cavalli R, Bocca C, Gabriel L, Gasco M. Cellular uptake and

cytotoxicity of solid lipid nanospheres (SLN) incorporating doxorubicin

or paclitaxel. Int J Pharm 2000;210:61-7.

Park EK, Kim SY, Lee SB, Lee YM. Folate-conjugated methoxy poly

(ethylene glycol)/poly (caprolactone) amphiphilic block copolymeric

micelles for tumor-targeted drug delivery. J Control Release